Equifax (NYSE:EFX – Get Free Report) had its price target reduced by stock analysts at Needham & Company LLC from $325.00 to $300.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has a “buy” rating on the credit services provider’s stock. Needham & Company LLC’s target price indicates a potential upside of 21.44% from the stock’s current price.
Other equities research analysts also recently issued research reports about the stock. Morgan Stanley reduced their price objective on shares of Equifax from $320.00 to $316.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Jefferies Financial Group reduced their price target on Equifax from $340.00 to $300.00 and set a “buy” rating for the company in a report on Wednesday, January 15th. Stifel Nicolaus dropped their price objective on Equifax from $305.00 to $284.00 and set a “buy” rating on the stock in a report on Wednesday, November 20th. Wolfe Research cut Equifax from an “outperform” rating to a “peer perform” rating in a research report on Thursday, December 12th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Equifax from $304.00 to $283.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 19th. Two investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $307.47.
Check Out Our Latest Research Report on Equifax
Equifax Stock Down 8.6 %
Equifax (NYSE:EFX – Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The credit services provider reported $2.12 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.12. Equifax had a net margin of 10.07% and a return on equity of 18.56%. As a group, research analysts expect that Equifax will post 7.27 earnings per share for the current year.
Insider Transactions at Equifax
In related news, EVP Lisa M. Nelson sold 551 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $260.39, for a total value of $143,474.89. Following the sale, the executive vice president now owns 11,697 shares of the company’s stock, valued at approximately $3,045,781.83. This represents a 4.50 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 1.66% of the company’s stock.
Hedge Funds Weigh In On Equifax
A number of institutional investors have recently made changes to their positions in the stock. Greenleaf Trust increased its position in Equifax by 2.2% during the 4th quarter. Greenleaf Trust now owns 1,702 shares of the credit services provider’s stock worth $434,000 after purchasing an additional 37 shares in the last quarter. Inspire Investing LLC grew its holdings in shares of Equifax by 4.2% during the fourth quarter. Inspire Investing LLC now owns 1,012 shares of the credit services provider’s stock worth $258,000 after buying an additional 41 shares in the last quarter. Cromwell Holdings LLC grew its holdings in shares of Equifax by 13.5% during the third quarter. Cromwell Holdings LLC now owns 371 shares of the credit services provider’s stock worth $109,000 after buying an additional 44 shares in the last quarter. Howard Capital Management Inc. raised its position in shares of Equifax by 5.4% in the fourth quarter. Howard Capital Management Inc. now owns 879 shares of the credit services provider’s stock valued at $224,000 after buying an additional 45 shares during the last quarter. Finally, Concurrent Investment Advisors LLC lifted its stake in shares of Equifax by 6.1% during the fourth quarter. Concurrent Investment Advisors LLC now owns 799 shares of the credit services provider’s stock valued at $204,000 after buying an additional 46 shares during the period. 96.20% of the stock is owned by institutional investors and hedge funds.
About Equifax
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Recommended Stories
- Five stocks we like better than Equifax
- What Do S&P 500 Stocks Tell Investors About the Market?
- Uber’s Business, Cash Flow, and AI are Why it Will Set a New High
- 3 Best Fintech Stocks for a Portfolio Boost
- Weak Guidance from Bristol-Myers Could Be Creating an Opportunity
- Utilities Stocks Explained – How and Why to Invest in Utilities
- These are the 3 Stocks Most Likely to Split in 2025
Receive News & Ratings for Equifax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax and related companies with MarketBeat.com's FREE daily email newsletter.